SparingVision

0 followers


SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal d... Read more

Industries

Headquarters

Paris, France

Employees

11-50

Links

Org chart

Stéphane Boissel
President & CEO

Stéphane Boissel

Collapse
Mehdi Gasmi
Chief Operating Officer
Stanislas Piot
Chief Financial Officer
Hélène Grimm
General Counsel / Directrice Juridique
Marie Uguen
SVP, Regulatory Affairs & QA
Florence Paliargues
VP Portfolio Program Management
Ryan Klimczak
VP, Intellectual Property
Anne-Sophie Gautron
Director Translational Sciences